LEO Pharma Inc. is a wholly-owned subsidiary of the LEO Foundation of Denmark. The Foundation is an independent Research Foundation specializing in dermatology, hemostasis and inflammation. The dermatology portfolio includes topical Fucidin®, the most often prescribed topical antibiotic in Canada, Dovobet® and Dovonex®, the most often prescribed brands for the management of psoriasis, as well as Fucidin®H for mild to moderate atopic dermatitis.

Our dermatology portfolio will expand with several new products coming to Canada within the next few years.

The LEO Foundation prides itself in its ability to generate the highest quality of research to support its product claims. This has been accomplished through an active network of world-class researchers, including more than 200 dermatologists within the Canadian healthcare system.

®registered trademark of LEO Pharmaceutical Products used under license by LEO Pharma Inc., Thornhill, Ontario

Click here to close this window
and return to the Dermatology Update Sponsors Page.